NSC16168 |
Katalog-Nr.GC36775 |
NSC16168 ist ein spezifischer Inhibitor von ERCC1-XPF mit einem IC50-Wert von 0,42 μM. NSC16168 hemmt die DNA-Reparatur und verstÄrkt die Wirksamkeit von CDDP bei Krebs.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 6837-93-0
Sample solution is provided at 25 µL, 10mM.
NSC16168 is a specific inhibitor of ERCC1-XPF, with an IC50 value of 0.42 μM. NSC16168 inhibits DNA repair and potentiates CDDP efficacy in cancer[1]. IC50: 0.42 μM (ERCC1-XPF)[1].
[1]. Arora S, et al. Identification of small molecule inhibitors of ERCC1-XPF that inhibit DNA repair and potentiate cisplatin efficacy in cancer cells. Oncotarget. 2016 Nov 15;7(46):75104-75117.
Average Rating: 5
(Based on Reviews and 11 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *